Literature DB >> 18408363

Role of angiotensin II on dihydrofolate reductase, GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion.

Yuyen Seujange1, Somchit Eiam-Ong, Thaweesak Tirawatnapong, Somchai Eiam-Ong.   

Abstract

BACKGROUND: The present study was conducted to investigate the role of renal ischemia-reperfusion (IR) and angiotensin II (ANG II) on mRNA and protein levels of renal dihydrofolate reductase (DHFR), GTP-cyclohydrolase 1 (GTP- CH 1), and endothelial and inducible nitric oxide synthase (eNOS and iNOS, respectively).
METHODS: Male Wistar rats were sham operated or received IR (30 min occlusion, and reperfusion for 1 day). Each group was treated separately with water, angiotensin-converting enzyme inhibitor (ACEI) and ANG II receptor type 1 blocker (ARB) for 1 day before the sham operation or IR, and continuously for 1 day after the operation. The mRNA and protein levels were detected by RT-PCR and Western blot, respectively.
RESULTS: IR decreased DHFR mRNA and protein levels (p < 0.01), both of which were restored by ACEI or ARB, whereas GTP-CH 1 expression was unaltered. IR suppressed eNOS dimer while enhancing the monomer (p < 0.01). IR augmented iNOS mRNA, total iNOS protein and iNOS monomer (all p < 0.01) which were attenuated by ACEI or ARB.
CONCLUSION: Our study is the first to demonstrate that the heightened ANG II in IR, via stimulation of ANG II receptor type 1, suppresses DHFR and eNOS dimer, while activating both iNOS mRNA and protein levels. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408363     DOI: 10.1159/000126927

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  6 in total

1.  Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity.

Authors:  Ling Gao; Karel Chalupsky; Enrico Stefani; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2009-08-03       Impact factor: 5.000

Review 2.  Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.

Authors:  Kirtiman Srivastava; Philip M W Bath; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

Review 3.  Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension.

Authors:  Qiang Li; Ji-Youn Youn; Hua Cai
Journal:  J Hypertens       Date:  2015-06       Impact factor: 4.844

4.  Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI.

Authors:  Jiandong Zhang; Nathan P Rudemiller; Mehul B Patel; QingQing Wei; Norah S Karlovich; Alexander D Jeffs; Min Wu; Matthew A Sparks; Jamie R Privratsky; Marcela Herrera; Susan B Gurley; Sergei A Nedospasov; Steven D Crowley
Journal:  J Am Soc Nephrol       Date:  2016-01-07       Impact factor: 10.121

5.  Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosis.

Authors:  Jang-Hee Cho; Soon-Youn Choi; Hye-Myung Ryu; Eun-Joo Oh; Ju-Min Yook; Ji-Sun Ahn; Hee-Yeon Jung; Ji-Young Choi; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

6.  Rapid nongenomic action of aldosterone on protein expressions of Hsp90( α and β ) and pc-Src in rat kidney.

Authors:  Somchit Eiam-Ong; Kittisak Sinphitukkul; Krissanapong Manotham; Somchai Eiam-Ong
Journal:  Biomed Res Int       Date:  2013-01-22       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.